Roger Dansey, M.D., is a biopharmaceutical leader with over two decades of experience in drug development and commercialization.
Roger Dansey, M.D., is a biopharmaceutical leader with over two decades of experience in drug development and commercialization, primarily in oncology and hematology. He has held significant leadership roles at companies such as Pfizer Oncology, Seagen, Merck Inc., Gilead Sciences, and Amgen. Dr. Dansey has contributed to the clinical development and approval of multiple cancer medicines.
Full founder directory · Investor directory · Company funding database · Fundraising library